Russia's Vaccine Diplomacy in Central Europe: Between a Political Campaign and a Business Project
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11230%2F21%3A10435748" target="_blank" >RIV/00216208:11230/21:10435748 - isvavai.cz</a>
Výsledek na webu
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=4CYO9Stslc" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=4CYO9Stslc</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.32422/mv-cjir.1820" target="_blank" >10.32422/mv-cjir.1820</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Russia's Vaccine Diplomacy in Central Europe: Between a Political Campaign and a Business Project
Popis výsledku v původním jazyce
Drawing on the concept of vaccine diplomacy, the article analyses Russia's efforts to promote its Sputnik V vaccine and the repercussions this had in two Central European EU member states which authorized the use of the Russian vaccine. The authors argue that for Russia, Sputnik V promotion was significant both as a business project and as a political enterprise, as it was supposed to enhance Russia's international status and help it in overcoming its post-Crimea isolation from the West. The results were mixed, however, as Russia's international credibility had been undermined by its previous policies. Thus, in Hungary the vaccine managed to gain some traction thanks to a government that preferred importing non-EU certified vaccines as part of its larger policy of fostering closer ties with the authoritarian great powers in Eurasia. In Slovakia, the vaccine deal with Russia caused a political crisis but eventually resulted in a very poor performance of Sputnik V as compared to EU-certified vaccines.
Název v anglickém jazyce
Russia's Vaccine Diplomacy in Central Europe: Between a Political Campaign and a Business Project
Popis výsledku anglicky
Drawing on the concept of vaccine diplomacy, the article analyses Russia's efforts to promote its Sputnik V vaccine and the repercussions this had in two Central European EU member states which authorized the use of the Russian vaccine. The authors argue that for Russia, Sputnik V promotion was significant both as a business project and as a political enterprise, as it was supposed to enhance Russia's international status and help it in overcoming its post-Crimea isolation from the West. The results were mixed, however, as Russia's international credibility had been undermined by its previous policies. Thus, in Hungary the vaccine managed to gain some traction thanks to a government that preferred importing non-EU certified vaccines as part of its larger policy of fostering closer ties with the authoritarian great powers in Eurasia. In Slovakia, the vaccine deal with Russia caused a political crisis but eventually resulted in a very poor performance of Sputnik V as compared to EU-certified vaccines.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
50601 - Political science
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2021
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Mezinárodní vztahy
ISSN
0323-1844
e-ISSN
—
Svazek periodika
56
Číslo periodika v rámci svazku
4
Stát vydavatele periodika
CZ - Česká republika
Počet stran výsledku
16
Strana od-do
131-146
Kód UT WoS článku
000727653900007
EID výsledku v databázi Scopus
2-s2.0-85121930896